Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Just three years old, the biopharma company brings a portfolio of clinical-stage incretin and amylin research programmes, including a phase II weekly and monthly injectable GLP-1 drug
Stimulant- and caffeine-free
Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption
This has a profound effect on both blood sugar control and appetite regulation, which often results in weight loss
US$ 21.69
US$ 28.43
US$ 20.34
US$ 29.53
US$ 28.01
US$ 21.44
US$ 26.43
US$ 23.83
US$ 20.08
